Thiazide and thiazide-like diuretics

A group of diuretics used for high blood pressure and for swelling from fluid build-up. The US label read for hydrochlorothiazide, a thiazide, lists high blood pressure and fluid build-up from congestive heart failure. The label read for chlorthalidone, which the label says differs chemically from the thiazides, lists the same two uses, and the US drug record places it in a thiazide-like group.

Also called Thiazide diuretics · Thiazide-like diuretics · Thiazides

  • Drug
  • In this atlas

Overview

Technical summary

Class page for a group made of two sets. MeSH descriptor D049993 (Sodium Chloride Symporter Inhibitors, last updated 2021-06-30) is a broad match: it is named for the mechanism, agents that inhibit sodium chloride symporters and act as diuretics, and it holds a concept for thiazide diuretics (Diuretics, Thiazide). The chemical descriptor D049971 (Thiazides) is not used as the match, because MeSH defines it as heterocyclic compounds, commonly the benzothiadiazines, so it does not cover the thiazide-like members. Two US labels were read: hydrochlorothiazide tablets (application ANDA202556, effective 2026-04-01 in openFDA; established pharmacologic class Thiazide Diuretic) and chlorthalidone tablets (application ANDA211627, effective 2022-11-24 in openFDA; established pharmacologic class Thiazide-like Diuretic). Both are generic labels, not the original brand. The hydrochlorothiazide label says the mechanism of the antihypertensive effect of thiazides is unknown. The label texts read state no age range for their uses. This page gives no dose, no trial result and no guideline statement; the pregnancy and other warnings in the labels were not recorded. Medicines of the group that have their own pages are filed under it.

Trials at a glance

The figures count the 5 registry trials in this atlas that name this drug or a product that contains it. Trials that use another name for it are not counted.

Trials
5
Phase 3 or 4
4
Recruiting
0
Regulatory decisions
0
Trials by phase (rows) and registry status (columns)
PhaseCompletedTerminatedAll statuses
Phase 2101
Phase 3213
Phase 4101
All phases415

Conditions these trials study

Sponsors with the most trials

The lead sponsor of each trial, as the registry names it.

Drugs in this class

3 drugs in this atlas are filed under Thiazide and thiazide-like diuretics, with the registry trials and FDA regulatory decisions this atlas holds for each. With Thiazide and thiazide-like diuretics itself, the class has 24 distinct trials and 69 distinct FDA decisions; a trial or decision that two of them share counts once there.

About this drug

Level
Class
Mechanism
The hydrochlorothiazide label says the mechanism of the antihypertensive effect of thiazides is unknown, and that the medicine affects the distal renal tubular mechanism of electrolyte reabsorption.

Classification codes

  • MeSH MeSH linked-data descriptor record fetched on 2026-11-09, lastUpdated 2021-06-30; the record states no yearly MeSH release D049993 Sodium Chloride Symporter Inhibitors

Claims and evidence

Context People with hypertension or with edema from congestive heart failure, as described in two US labels of a thiazide and a thiazide-like diuretic

Recipient
Recipient not specified
Population
Patients described in the indications sections of the two labels: patients with hypertension, and patients with edema associated with congestive heart failure (among other causes the labels list).
Care setting
Prescription medicine, as described in the US labels
Geography
United States (US drug labels)
Life stage
Not stated in the passages read
Gestational age
Not reported
Postnatal age
Not reported
Follow-up
Not applicable (label statement)
Eligibility: 2 inclusion criteria; exclusion criteria not stated
Included
  • Hypertension
  • Edema associated with congestive heart failure
Excluded
None stated
  • Description Evidence stage not applicable Certainty not assessed

    Two US generic labels were read. The label of hydrochlorothiazide tablets (Accord Healthcare Inc., application ANDA202556; the version dated 2026-04-01 in openFDA) calls the medicine a diuretic and antihypertensive and lists the management of hypertension and adjunctive therapy in edema associated with congestive heart failure. The label of chlorthalidone tablets (Unichem Pharmaceuticals (USA), Inc., application ANDA211627; the version dated 2022-11-24 in openFDA) calls the medicine a monosulfamyl diuretic that differs chemically from thiazide diuretics, and lists the management of hypertension and the same heart failure edema use. openFDA's records give the established pharmacologic class Thiazide Diuretic for the first label and Thiazide-like Diuretic for the second. MeSH says the thiazide term commonly refers to the benzothiadiazines used as diuretics. It files thiazide diuretics as a concept of the descriptor Sodium Chloride Symporter Inhibitors, agents that act as diuretics.

    Applies to Recipient not specified People with hypertension or with edema from congestive heart failure, as described in two US labels of a thiazide and a thiazide-like diuretic

    Certainty method
    Not assessed
    Limitations
    This claim records what two US generic labels say. It is not a finding about how well either medicine works, and no trial result is recorded for it in this atlas. The pharmacologic class names come from openFDA's record of each label. The labels list other uses and a pregnancy statement that were not recorded; contraindications, other warnings, interactions and dosing were not recorded either. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
    Last checked
    2026-11-09
    Next evidence check due
    Not scheduled
    Sources and citations (10)
    1. Supports openFDA drug label record for hydrochlorothiazide tablets, Accord Healthcare Inc. label: indications and class description

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id babb1b20-fe82-40ba-8e7a-0c56fe433b4a (manufacturer Accord Healthcare Inc., application ANDA202556), returned on 2026-11-09. The label text is dated 2026-04-01 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].indications_and_usage[0], INDICATIONS AND USAGE
      How it applies
      Hydrochlorothiazide: hypertension and heart failure edema.
      Retrieved
      Source effective date
      2026-04-01
      Source state
      Current
      Version fingerprint
      84f40f21b1e0fc57063909f4dcab71d58f55ce6b6bb99055c663b27c106c11f6
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    2. Supports openFDA drug label record for hydrochlorothiazide tablets, Accord Healthcare Inc. label: indications and class description

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id babb1b20-fe82-40ba-8e7a-0c56fe433b4a (manufacturer Accord Healthcare Inc., application ANDA202556), returned on 2026-11-09. The label text is dated 2026-04-01 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].openfda.pharm_class_epc[0]
      How it applies
      Established pharmacologic class in openFDA: Thiazide Diuretic.
      Retrieved
      Source effective date
      2026-04-01
      Source state
      Current
      Version fingerprint
      84f40f21b1e0fc57063909f4dcab71d58f55ce6b6bb99055c663b27c106c11f6
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    3. Background openFDA drug label record for hydrochlorothiazide tablets, Accord Healthcare Inc. label: indications and class description

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id babb1b20-fe82-40ba-8e7a-0c56fe433b4a (manufacturer Accord Healthcare Inc., application ANDA202556), returned on 2026-11-09. The label text is dated 2026-04-01 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].effective_time
      How it applies
      Effective date of the label text read, 20260401.
      Retrieved
      Source effective date
      2026-04-01
      Source state
      Current
      Version fingerprint
      84f40f21b1e0fc57063909f4dcab71d58f55ce6b6bb99055c663b27c106c11f6
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    4. Supports openFDA drug label record for chlorthalidone tablets, Unichem Pharmaceuticals (USA), Inc. label: indications and class description

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 01065eda-7515-46bc-b858-a062c3aa35bd (manufacturer Unichem Pharmaceuticals (USA), Inc., application ANDA211627), returned on 2026-11-09. The label text is dated 2022-11-24 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].indications_and_usage[0], INDICATIONS AND USAGE
      How it applies
      Chlorthalidone: hypertension and heart failure edema.
      Retrieved
      Source effective date
      2022-11-24
      Source state
      Current
      Version fingerprint
      5cfb84ceb2ed66b3aa0c9b6a9ab0966fb7ac8c9623874762f484f79353a1b630
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    5. Supports openFDA drug label record for chlorthalidone tablets, Unichem Pharmaceuticals (USA), Inc. label: indications and class description

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 01065eda-7515-46bc-b858-a062c3aa35bd (manufacturer Unichem Pharmaceuticals (USA), Inc., application ANDA211627), returned on 2026-11-09. The label text is dated 2022-11-24 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].description[0], DESCRIPTION
      How it applies
      Chlorthalidone differs chemically from thiazide diuretics.
      Retrieved
      Source effective date
      2022-11-24
      Source state
      Current
      Version fingerprint
      5cfb84ceb2ed66b3aa0c9b6a9ab0966fb7ac8c9623874762f484f79353a1b630
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    6. Supports openFDA drug label record for chlorthalidone tablets, Unichem Pharmaceuticals (USA), Inc. label: indications and class description

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 01065eda-7515-46bc-b858-a062c3aa35bd (manufacturer Unichem Pharmaceuticals (USA), Inc., application ANDA211627), returned on 2026-11-09. The label text is dated 2022-11-24 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].openfda.pharm_class_epc[0]
      How it applies
      Established pharmacologic class in openFDA: Thiazide-like Diuretic.
      Retrieved
      Source effective date
      2022-11-24
      Source state
      Current
      Version fingerprint
      5cfb84ceb2ed66b3aa0c9b6a9ab0966fb7ac8c9623874762f484f79353a1b630
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    7. Background openFDA drug label record for chlorthalidone tablets, Unichem Pharmaceuticals (USA), Inc. label: indications and class description

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 01065eda-7515-46bc-b858-a062c3aa35bd (manufacturer Unichem Pharmaceuticals (USA), Inc., application ANDA211627), returned on 2026-11-09. The label text is dated 2022-11-24 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].effective_time
      How it applies
      Effective date of the label text read, 20221124.
      Retrieved
      Source effective date
      2022-11-24
      Source state
      Current
      Version fingerprint
      5cfb84ceb2ed66b3aa0c9b6a9ab0966fb7ac8c9623874762f484f79353a1b630
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    8. Supports MeSH scope note for descriptor D049971 (Thiazides)

      Dataset · U.S. National Library of Medicine · Edition MeSH linked-data record of the preferred concept M0471776 of descriptor D049971, fetched 2026-11-09. The scope note is on this concept record, not on the descriptor record. · MeSH: M0471776

      Locator
      scopeNote.@value
      How it applies
      MeSH scope note: what the thiazide term refers to.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      8f55829c320bca01d90bd277a7bba2f780bac3669a7cd29cf94af0e707c25da1
      Reuse basis
      The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. Source: National Library of Medicine. This copy was fetched on 2026-11-09 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
    9. Supports MeSH scope note for descriptor D049993 (Sodium Chloride Symporter Inhibitors)

      Dataset · U.S. National Library of Medicine · Edition MeSH linked-data record of the preferred concept M0471877 of descriptor D049993, fetched 2026-11-09. The scope note is on this concept record, not on the descriptor record. · MeSH: M0471877

      Locator
      scopeNote.@value
      How it applies
      MeSH scope note of the matched descriptor: sodium chloride symporter inhibitors act as diuretics.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      a43244ed8eef72fe5a73e6d72636c10c164cd63eb440860890bb960d19857b07
      Reuse basis
      The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. Source: National Library of Medicine. This copy was fetched on 2026-11-09 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
    10. Supports MeSH concept M0006628 (Diuretics, Thiazide) of descriptor D049993 (Sodium Chloride Symporter Inhibitors)

      Dataset · U.S. National Library of Medicine · Edition MeSH linked-data record of concept M0006628, which descriptor D049993 lists among its concepts, fetched 2026-11-09. The descriptor record is its own source, cardio:mesh-d049993. · MeSH: M0006628

      Locator
      label.@value
      How it applies
      MeSH concept of the matched descriptor named Diuretics, Thiazide.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      7119cc10d5b13289e5912295254fa99e0ea0c9a5ef96985ca56463f13bc7d0d4
      Reuse basis
      The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. Source: National Library of Medicine. This copy was fetched on 2026-11-09 and may not reflect the most current data. The raw bytes are committed in the atlas repository.

Clinical links

Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.

Registry records

Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry trials 5

Record details

Record id
cardio:thiazide-and-thiazide-like-diuretics
Content hash
6efd2718f01e794731d09599c48c12e0fb7599e4d5fc85389bcf8fc94874c4bf